Tower Research Capital LLC TRC lessened its holdings in shares of Novanta Inc. (NASDAQ:NOVT – Free Report) by 34.5% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,121 shares of the technology company’s stock after selling 1,646 shares during the quarter. Tower Research Capital LLC TRC’s holdings in Novanta were worth $477,000 at the end of the most recent quarter.
A number of other large investors also recently made changes to their positions in NOVT. Empowered Funds LLC purchased a new position in Novanta during the fourth quarter valued at approximately $26,000. Huntington National Bank grew its holdings in shares of Novanta by 53.6% during the 4th quarter. Huntington National Bank now owns 430 shares of the technology company’s stock valued at $66,000 after acquiring an additional 150 shares in the last quarter. SBI Securities Co. Ltd. acquired a new position in shares of Novanta in the fourth quarter worth $97,000. Venturi Wealth Management LLC increased its stake in shares of Novanta by 6,500.0% in the fourth quarter. Venturi Wealth Management LLC now owns 726 shares of the technology company’s stock worth $111,000 after acquiring an additional 715 shares during the last quarter. Finally, KBC Group NV raised its holdings in shares of Novanta by 41.6% during the fourth quarter. KBC Group NV now owns 1,500 shares of the technology company’s stock worth $229,000 after acquiring an additional 441 shares in the last quarter. Institutional investors and hedge funds own 98.35% of the company’s stock.
Novanta Price Performance
NASDAQ NOVT opened at $117.71 on Wednesday. The company has a quick ratio of 1.81, a current ratio of 2.79 and a debt-to-equity ratio of 0.61. The stock has a market capitalization of $4.23 billion, a PE ratio of 70.49 and a beta of 1.42. Novanta Inc. has a 12-month low of $98.76 and a 12-month high of $187.12. The company has a 50 day moving average price of $127.39 and a two-hundred day moving average price of $148.91.
Wall Street Analysts Forecast Growth
Separately, Robert W. Baird dropped their target price on Novanta from $169.00 to $160.00 and set a “neutral” rating on the stock in a research report on Monday, March 3rd.
Read Our Latest Stock Report on Novanta
Novanta Profile
Novanta, Inc engages in the provision of core technology solutions to healthcare and advanced industrial original equipment manufacturers. It operates through the following segments: Photonics, Vision, and Precision Motion. The Photonics segment designs, manufactures, and markets photonics-based solutions, including laser scanning and laser beam delivery, CO2 laser, continuous wave and ultrafast laser, and optical light engine products.
Recommended Stories
- Five stocks we like better than Novanta
- 3 Defense Stocks Set to Benefit From Increased Military Spending
- Don’t Be Fooled by the Bounce: The Market Storm Isn’t Over Yet
- Best Aerospace Stocks Investing
- Coca-Cola Company Stock Can Bubble to New Highs This Year
- How to Calculate Options Profits
- 3 Stocks Lifting 2025 Guidance Despite Market Jitters
Want to see what other hedge funds are holding NOVT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Novanta Inc. (NASDAQ:NOVT – Free Report).
Receive News & Ratings for Novanta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novanta and related companies with MarketBeat.com's FREE daily email newsletter.